Slate Path Capital LP Teva Pharmaceutical Industries LTD Transaction History
Slate Path Capital LP
- $6.33 Billion
- Q3 2024
A detailed history of Slate Path Capital LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Slate Path Capital LP holds 13,668,233 shares of TEVA stock, worth $228 Million. This represents 3.89% of its overall portfolio holdings.
Number of Shares
13,668,233
Previous 20,191,184
32.31%
Holding current value
$228 Million
Previous $328 Million
24.93%
% of portfolio
3.89%
Previous 6.44%
Shares
6 transactions
Others Institutions Holding TEVA
# of Institutions
626Shares Held
573MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$716 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$603 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$575 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$480 Million3.32% of portfolio
-
Exor Capital LLP London, X026.5MShares$441 Million14.79% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.5B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...